ZA200610708B - Compositions comprising nebivolol - Google Patents

Compositions comprising nebivolol

Info

Publication number
ZA200610708B
ZA200610708B ZA200610708A ZA200610708A ZA200610708B ZA 200610708 B ZA200610708 B ZA 200610708B ZA 200610708 A ZA200610708 A ZA 200610708A ZA 200610708 A ZA200610708 A ZA 200610708A ZA 200610708 B ZA200610708 B ZA 200610708B
Authority
ZA
South Africa
Prior art keywords
nebivolol
compositions
Prior art date
Application number
ZA200610708A
Inventor
Davis Eric
O'donnell John
Bottini Peter Bruce
Original Assignee
Mylan Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Lab Inc filed Critical Mylan Lab Inc
Publication of ZA200610708B publication Critical patent/ZA200610708B/en

Links

ZA200610708A 2004-06-04 2006-12-19 Compositions comprising nebivolol ZA200610708B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57742304P 2004-06-04 2004-06-04

Publications (1)

Publication Number Publication Date
ZA200610708B true ZA200610708B (en) 2008-09-25

Family

ID=38710340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610708A ZA200610708B (en) 2004-06-04 2006-12-19 Compositions comprising nebivolol

Country Status (2)

Country Link
CN (1) CN101022791B (en)
ZA (1) ZA200610708B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102203229B1 (en) * 2016-01-08 2021-01-14 에리슨제약(주) Pharmaceutical composition with improved dissolution rate comprising nebivolol
CN107625762B (en) * 2016-07-25 2021-11-19 上海璃道医药科技有限公司 New application of naphthalene ring medicine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030414A1 (en) * 2000-04-03 2003-08-20 Astrazeneca Ab PHARMACEUTICAL COMBINATION THAT INCLUDES A BLOCKING BETA AND A REDUCED HMG-COA INHIBITOR, PHARMACEUTICAL FORMULATION, TRANSPORTABLE PARTS EQUIPMENT, USE OF THIS COMBINATION AND THIS FORMULATION TO PREPARE MEDICATIONS

Also Published As

Publication number Publication date
CN101022791B (en) 2011-11-16
CN101022791A (en) 2007-08-22

Similar Documents

Publication Publication Date Title
AP2815A (en) Compositions comprising nebivolol
EP1718714A4 (en) Tracer-containing compositions
ZA200904425B (en) Nemathical compositions
GB0409375D0 (en) Phytoactive composition
ZA200706287B (en) Glucoronidated Nebivolol
HK1204570A1 (en) Compositions comprising nebivolol
EP1726304A4 (en) Solifenacin-containing composition
GB0405406D0 (en) Anti-vaginitis compositions
GB0425795D0 (en) Composition
GB0416861D0 (en) Composition
GB0410038D0 (en) Composition
GB0414803D0 (en) Composition
GB0415981D0 (en) Composition
GB0417357D0 (en) Composition
ZA200701197B (en) Compositions
ZA200710355B (en) Compositions comprising nebivolol
GB0410140D0 (en) Compositions
ZA200610708B (en) Compositions comprising nebivolol
GB0420627D0 (en) Monoglyceride-containing compositions
GB0425445D0 (en) Novel compositions
GB0417388D0 (en) Composition
GB0517958D0 (en) Weathered-effect composition
GB0409598D0 (en) Composition
GB0407814D0 (en) Compositions
GB0401515D0 (en) Compositions